XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 33.63

-2.5%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: bob zagorin who wrote (17127)	3/11/2005 4:04:27 AM
From: bob zagorin	of 17367

Xoma shares soar 35% on contract By Carolyn Pritchard, MarketWatch Last Update: 7:18 PM ET March 10, 2005 SAN FRANCISCO (MarketWatch) - Xoma Ltd.'s shares rocketed higher by 35 percent following Thursday's closing bell after the company said it was awarded a $15 million contract from a unit of the National Institutes of Health. Xoma shares added 37 cents in late trading to change hands for $1.41. Under terms of the 18-month contract from the National Institute of Allergy and Infectious Diseases, Berkeley, Calif.-based Xoma (XOMA: news, chart, profile) will produce three botulinum neurotoxin monoclonal antibodies designed to protect against the effects of biological agents used in terrorism. SRI International, an independent, nonprofit research institute based in Menlo Park, Calif. will be a subcontractor under the contract and will develop potency assays to support antibody characterization, Xoma said in a company statement.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next